The lawsuit was filed by Melvin B., a man from Pennsylvania who was implanted with the Eclipse® Inferior Vena Cava Filter (“IVC Filter”) manufactured by C.R. Bard Inc. and Bard Peripheral Vascular.
The IVC Filter was implanted on March 4, 2014 at University of Pennsylvania Medical Center Mercy Hospital in Pittsburgh, Pennsylvania by Dr. Samuel T. Simone.
The purpose of implanting the IVC Filter was to prevent a pulmonary embolism (blood clot in the lungs).
On September 1, 2016, the plaintiff underwent an attempted IVC Filter removal procedure. At that time, it was discovered that the Eclipse® filter had fractured into 3 pieces and migrated.
One piece was successfully retrieved. On September 24, 2016, the plaintiff underwent another attempted IVC Filter removal procedure. After multiple unsuccessful attempts, only 2 out of 3 broken filter fragments were retrieved.
C.R. Bard is accused of negligence for selling a defective medical device and failing to warn about safety risks.
The potential serious injuries include death, hemorrhage, irregular heart rhythm, symptoms similar to a heart attack, severe and persistent pain, perforations of blood vessels and organs, and an inability to remove the IVC Filter.
The lawsuit was filed on June 10, 2018 in the Court of Common Pleas of Allegheny County, Pennsylvania (Civil Division) — Case No. GD-18-007387.
There are now over 3,800 other IVC filter lawsuits pending against C.R. Bard in Multi-District Litigation (MDL No. 2641) — In Re: Bard IVC Filters Products Liability Litigation.
The plaintiff is represented by Ben C. Martin of The Law Offices of Ben C. Martin in Dallas, Texas. He serves on the plaintiffs’ steering committee of the Bard IVC Filter MDL.